Worth Venture Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,602
Closed -$84K 195
2022
Q3
$84K Sell
10,602
-2,226
-17% -$17.6K 0.05% 129
2022
Q2
$249K Hold
12,828
0.15% 104
2022
Q1
$482K Buy
12,828
+1,365
+12% +$51.3K 0.22% 80
2021
Q4
$644K Buy
+11,463
New +$644K 0.32% 74